Study aims to identify methodology for least amount of variation, greatest test-retest reliability
Study aims to identify methodology for least amount of variation, greatest test-retest reliability
Study aims to identify methodology for least amount of variation, greatest test-retest reliability
Combination therapy benefits from laser in the mix for DME, other conditions
Patients tolerate therapy well; high safety profile allows re-treatment as necessary
Bausch + Lomb's Yolande Barnard shares an update on the FDA approval of XIPERE for the treatment of macular edema associated with uveitis.
Javier Zarranz-Ventura MD, PhD, FEBO, discusses the key highlights from his presentation on a clinical investigation of suitable naïve versus pre-treated DME patients, and what it means for future research.
Carolyn Majcher, OD, FAAO, and Rishi Singh, MD, discuss new and upcoming clinical trials, investigational therapies, and diagnostic tools for the treatment of diabetic retinopathy and diabetic macular edema (DR/DME).
Despite cost, advantages include sensitivity, improved outcomes
Used as an adjunct, ST laser therapy may reduce the treatment burden for patients while maintaining visual acuity.